Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05989178

Prospective Recurrent Pregnancy Loss Registry

The purpose of this Registry is to prospectively collect data of Recurrent Pregnancy Loss (RPL) patients attending the specialized care centre at the BC Women's Hospital, in order to evaluate investigation practices, treatment options, and outcomes for this patient population over time.

Recruiting

Interested in participating?

Request Info

Key information

Age range

15 year–49 year

Sex eligibility

Female

Study type

Observational

Primary location

BC Women's Hospital & Health Centre

Vancouver, British Columbia, V6H 3N1, Canada

Location status: Recruiting

Location contact

Mohamed A. Bedaiwy, MD, PhD

CONTACT

[email protected]

604-875-2000 ext. 4310

About this study

The Recurrent Pregnancy Loss Program at the BC Women's Centre for Reproductive Health is the only tertiary care centre of its kind in British Columbia, and has provided specialized and comprehensive care to RPL patients for the past 15 years. Using a team-based collaborative model, the program provides point-of-care investigations, surgical treatment, clinical management, education, and grief counselling.

All RPL patients are asked to complete the intake questionnaire prior to their initial visit at the clinic. If the patient provides their consent to take part in research, their data will be copied from the clinical database to the research database. The questionnaire includes information regarding patient demographics, obstetric history, gynecological history, personal and medical history, family history and partner information. Additionally, data will also be collected from patient charts, follow-up questionnaires sent once a year for the next 5 years following the patient's initial visit, and medical records from fertility clinics and general practitioners when available.

The online data registry is housed in the Research Electronic Data Capture (REDCap) platform located at BC Children's Hospital (BCCH).

As an optional component of this study, patients invited to join the registry will also be presented with the option to register with the BCCH BioBank to store their tissue samples collected in the RPL clinic for clinical & diagnostic purposes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients seen at the BC Women's Recurrent Pregnancy Loss Clinic with recurrent pregnancy loss, defined as ≥2 pregnancy losses before 20 weeks of gestation.

Exclusion criteria

  • Patients at BC Women's Recurrent Pregnancy Loss Clinic seen for reasons other than recurrent pregnancy loss.

Treatment and study plan

Data Registry

Other

Follow-up questionnaires sent every year for the 5 years following the patient's initial visit.

Primary outcomes

  1. Live Birth

    Time frame: 5 years

    Percent of patients with a live birth within 5 years after initial visit at the clinic.

Study contacts

Contact information is provided by the study sponsor or research team.

Mohamed A. Bedaiwy, MD, PhD

CONTACT

[email protected]

604-875-2000 ext. 4310

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Official study title

Prospective Recurrent Pregnancy Loss (ProRPL) Registry

Important dates

Study start
2022
Primary completion
2032
Study completion
2032
First posted
Aug 14, 2023
Registry last updated
Dec 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.